One of the most challenging issues for clinical trial investigators, sponsors and regulatory officials in the interpretation of experimental results that are composed of the results of multiple statistical analyses. These analyses may included the effect of therapy on multiple endpoints, the assessment of subgroup analyses, and the evaluation of a dose-response relationship in complex mixtures.
